TRICUSPID STENOSIS

Course overview

TRICUSPID STENOSIS (TS) IS A RELATIVELY RARE VALVULAR HEART DISEASE, ACCOUNTING FOR LESS THAN 1% OF CASES. IT IS THE NARROWING OF THE TRICUSPID VALVE DUE TO ANY ETIOLOGY. THE CLINICAL SEQUEL OF THE CAUSE OF TRICUSPID STENOSIS CAN BE BROADLY CLASSIFIED INTO THREE CATEGORIES: ACQUIRED, CONGENITAL, AND IATROGENIC. IS PREDOMINANTLY SYSTEMIC CONGESTION. IT MOST OFTEN CO-EXISTS WITH MITRAL VALVE PATHOLOGY, ESPECIALLY IN PATIENTS WITH RHEUMATIC HEART DISEASE. THERE ARE VARIOUS CAUSES OF THE DISEASE, INCLUDING SYSTEMIC ILLNESSES AND DRUGS; THE CAUSE OF TRICUSPID STENOSIS CAN BE BROADLY CLASSIFIED INTO THREE CATEGORIES: ACQUIRED, CONGENITAL, AND IATROGENIC. THIS ACTIVITY DESCRIBES THE EVALUATION AND MANAGEMENT OF TRICUSPID STENOSIS AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN EVALUATING AND TREATING PATIENTS WITH THIS CONDITION.